|
1
|
Song Z, Wu Y, Yang J, Yang D and Fang X:
Progress in the treatment of advanced gastric cancer. Tumour Biol.
39(1010428317714626)2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980-2011), with
predictions to. 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Charalampakis N, Economopoulou P,
Kotsantis I, Tolia M, Schizas D, Liakakos T, Elimova E, Ajani JA
and Psyrri A: Medical management of gastric cancer: A 2017 update.
Cancer Med. 7:123–133. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Russo A, Li P and Strong VE: Differences
in the multimodal treatment of gastric cancer: East versus west. J
Surg Oncol. 115:603–614. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hamashima C: Current issues and future
perspectives of gastric cancer screening. World J Gastroenterol.
20:13767–13774. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hao XL, Han F, Zhang N, Chen HQ, Jiang X,
Yin L, Liu WB, Wang DD, Chen JP, Cui ZH, et al: TC2N, a novel
oncogene, accelerates tumor progression by suppressing p53
signaling pathway in lung cancer. Cell Death Differ. 26:1235–1250.
2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Farah CA and Sossin WS: The role of C2
domains in PKC signaling. Adv Exp Med Biol. 740:663–683.
2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kabekkodu SP, Bhat S, Radhakrishnan R,
Aithal A, Mascarenhas R, Pandey D, Rai L, Kushtagi P, Mundyat GP
and Satyamoorthy K: DNA promoter methylation-dependent
transcription of the double C2-like domain β (DOC2B) gene regulates
tumor growth in human cervical cancer. J Biol Chem.
289:10637–10649. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Choi HY, Park N, Na JB, Ko ES, Park JY and
Yoo JC: Direct binding of Copine3 with Jab1 activates downstream
ErbB2 signaling and motility in SKBr3 breast cancer cells. Oncol
Rep. 35:1147–1152. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hao X, Gao LY, Zhang N, Chen H, Jiang X,
Liu W, Ao L, Cao J, Han F and Liu J: Tac2-N acts as a novel
oncogene and promotes tumor metastasis via activation of NF-κB
signaling in lung cancer. J Exp Clin Cancer Res.
38(319)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hao XL, Gao LY, Deng XJ, Han F, Chen HQ,
Jiang X, Liu WB, Wang DD, Chen JP, Cui ZH, et al: Identification of
TC2N as a novel promising suppressor of PI3K-AKT signaling in
breast cancer. Cell Death Dis. 10(424)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang X, Yang B, She Y and Ye Y: The lncRNA
TP73-AS1 promotes ovarian cancer cell proliferation and metastasis
via modulation of MMP2 and MMP9. J Cell Biochem. 119:7790–7799.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tian S, Wang X and Proud CG: Oncogenic MNK
signalling regulates the metastasis suppressor NDRG1. Oncotarget.
8:46121–46135. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fu Y, Wei J, Dai X and Ye Y: Increased
NDRG1 expression attenuate trophoblast invasion through ERK/MMP-9
pathway in preeclampsia. Placenta. 51:76–81. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Battistella C and Klok HA: Reversion of
P-gp-mediated drug resistance in ovarian carcinoma cells with
PHPMA-zosuquidar conjugates. Biomacromolecules. 18:1855–1865.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ciesielski M, Kruszewski WJ, Walczak J,
Szajewski M, Szefel J, Wydra J, Buczek T and Czerepko M: Analysis
of postoperative morbidity and mortality following surgery for
gastric cancer. Surgeon volume as the most significant prognostic
factor. Prz Gastroenterol. 12:215–221. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Willmer T, Peres J, Mowla S, Abrahams A
and Prince S: The T-Box factor TBX3 is important in S-phase and is
regulated by c-Myc and cyclin A-CDK2. Cell Cycle. 14:3173–3183.
2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wen Q, Luo K, Huang H, Liao W and Yang H:
Xanthoxyletin inhibits proliferation of human oral squamous
carcinoma cells and induces apoptosis, autophagy, and cell cycle
arrest by modulation of the MEK/ERK signaling pathway. Med Sci
Monit. 25:8025–8033. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Galderisi U, Jori FP and Giordano A: Cell
cycle regulation and neural differentiation. Oncogene.
22:5208–5219. 2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu W, Hua S, Dai Y, Yuan Y, Yang J, Deng
J, Huo Y, Chen X, Teng B, Yu X and Zhang Y: Roles of Cx43 and
AKAP95 in ovarian cancer tissues in G1/S phase. Int J Clin Exp
Pathol. 8:14315–14324. 2015.PubMed/NCBI
|
|
23
|
Yao Y, Yang X, Sun L, Sun S, Huang X, Zhou
D, Li T, Zhang W, Abumrad NA, Zhu X, et al: Fatty acid
2-hydroxylation inhibits tumor growth and increases sensitivity to
cisplatin in gastric cancer. EBioMedicine. 41:256–267.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Luo Y, Zha L, Luo L, Chen X, Zhang Q, Gao
C, Zhuang X, Yuan S and Qiao T: [6]-Gingerol enhances the cisplatin
sensitivity of gastric cancer cells through inhibition of
proliferation and invasion via PI3K/AKT signaling pathway.
Phytother Res. 33:1353–1362. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Wei X, Gao M, Ahmed Y, Gao M, Liu W, Zhang
Y, Xie X, Zhao Q, Wang H and Gu K: MicroRNA-362-5p enhances the
cisplatin sensitivity of gastric cancer cells by targeting
suppressor of zeste 12 protein. Oncol Lett. 18:1607–1616.
2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang Q, Zhu C, Zhang Y, Wang Y, Wang Y,
Zhu L, Yang X, Li J, Nie H, Jiang S, et al: Molecular analysis of
gastric cancer identifies genomic markers of drug sensitivity in
Asian gastric cancer. J Cancer. 9:2973–2980. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Liu F, Yin R, Chen X, Chen W, Qian Y, Zhao
Y, Jiang Y, Ma D, Hu T, Yu T, et al: Over-expression of miR-206
decreases the Euthyrox-resistance by targeting MAP4K3 in papillary
thyroid carcinoma. Biomed Pharmacother. 114(108605)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cantore M, Capparelli E, Berardi F,
Perrone R and Colabufo NA: Clinical pharmacokinetic and metabolism
of PET radiotracers for imaging P-glycoprotein in chemoresistant
tumor of colorectal cancer. Curr Drug Metab. 12:985–988.
2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tan B, Li Y, Zhao Q, Fan L and Wang D:
ZNF139 increases multidrug resistance in gastric cancer cells by
inhibiting miR-185. Biosci Rep. 38(BSR20181023)2018.PubMed/NCBI View Article : Google Scholar
|
